Access to continuous glucose monitor hailed as life-changing
Published on 15 August 2022
Following the latest NICE guidelines, every person living with the condition is now eligible for a CGM – a wearable sensor allowing people to check their glucose levels with a one-second scan.
Normally more expensive than their flash monitor counterparts – which record glucose levels by scanning a sensor – the NHS agreed on a new cost-effective deal with manufacturers GlucoRX, meaning they have been available for people on prescription at a more cost-effective price.
It is estimated that NHS England spends around £10 billion a year on diabetes-related conditions – which accounts for around 10% of its entire budget.
According to the NHS, tools like continuous glucose monitoring, which help people better manage their condition and reduce associated illness and hospitalisations, will reduce costs in the long run.
Chris Chapman, a Chief Operating Officer of GlucoRx, said: “We are delighted that our life-changing CGM devices are having such a positive effect on the lives of those with type 1 diabetes.
“We are proud to be the creators of one of the first CGMs to be available on prescription for every NHS patient with type 1 diabetes.
“It is an honour to work with the NHS on such a big project which will improve the quality of life for thousands of people with the condition.”
Research recently presented at the Diabetes UK Professional Conference 2022 revealed that flash monitoring not only helps to improve blood glucose levels in people with type 1 diabetes, but also has a positive effect on their quality of life.